{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:44:28Z","timestamp":1786995868642,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HPF\/2010\/17"],"award-info":[{"award-number":["HPF\/2010\/17"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["TRA\/2007\/5"],"award-info":[{"award-number":["TRA\/2007\/5"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.pnpbp.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:35:22Z","timestamp":1540334122000},"page":"380-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Peripheral blood E2F1 mRNA in depression and following electroconvulsive therapy"],"prefix":"10.1016","volume":"89","author":[{"given":"Claire L.","family":"McGrory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-570X","authenticated-orcid":false,"given":"Erik","family":"Kolshus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2018.10.011_bb0005","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.1193692","article-title":"miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants","volume":"329","author":"Baudry","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0010","series-title":"Handbook of Depression: Treatment, Assessment, and Research","author":"Beckham","year":"1985"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.55782\/ane-2014-1974","article-title":"Vascular endothelial growth factor a gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins","volume":"74","author":"Berent","year":"2014","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/excr.1994.1093","article-title":"Induction of a common pathway of apoptosis by staurosporine","volume":"211","author":"Bertrand","year":"1994","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0025","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","article-title":"miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database","volume":"44","author":"Chou","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0030","first-page":"739","article-title":"Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis","volume":"6","author":"DeGregori","year":"2006","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00311","article-title":"E2F1, a novel regulator of metabolism","author":"Denechaud","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb2000","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/gcc.20580","article-title":"Deregulated expression of miR-106a predicts survival in human colon cancer patients","volume":"47","author":"Diaz","year":"2008","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/MCB.20.1.273-285.2000","article-title":"Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor","volume":"20","author":"Dimri","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0045","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1101\/gad.282145.116","article-title":"RB1: a prototype tumor suppressor and an enigma","volume":"30","author":"Dyson","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cytogfr.2016.02.001","article-title":"E2F1 transcription factor and its impact on growth factor and cytokine signaling","volume":"31","author":"Ertosun","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0055","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version. Patient Ed","author":"First","year":"1995"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0014-5793(02)03270-2","article-title":"E2F1 pathways to apoptosis","volume":"529","author":"Ginsberg","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0065","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1074\/jbc.275.16.11553","article-title":"E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3","volume":"275","author":"Giovanni","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0070","first-page":"6501","article-title":"Inhibition of e2f-1 transactivation by direct binding of the retinoblastoma protein","volume":"13","author":"Helin","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data","author":"Hellemans","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpsychires.2009.08.015","article-title":"Altered gene expression of histone deacetylases in mood disorder patients","volume":"44","author":"Hobara","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1471-4159.2000.0750091.x","article-title":"The transcription factor E2F1 modulates apoptosis of neurons","volume":"75","author":"Hou","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb2015","article-title":"Cyclin D2\/D3-retinoblastoma protein-E2F1 suppression contributes to homocysteine-induced endothelial cell growth inhibition","volume":"25","author":"Jan","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnen\/61.4.358","article-title":"Altered distribution of cell cycle transcriptional regulators during Alzheimer disease","volume":"61","author":"Jordan-Sciutto","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biopsych.2004.10.025","article-title":"Activation of Cdk2-pRB-E2F1 cell cycle pathway by repeated electroconvulsive shock in the rat frontal cortex","volume":"57","author":"Kim","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/acps.12191","article-title":"When less is more - microRNAs and psychiatric disorders","volume":"129","author":"Kolshus","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0105","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/acps.12821","article-title":"Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression","volume":"136","author":"Kolshus","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(86)90386-7","article-title":"Identification of a cellular transcription factor involved in e1a transactivation","volume":"45","author":"Kovesdi","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ddr.21278","article-title":"Validated microRNA target databases: an evaluation","volume":"76","author":"Lee","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(\u2212Delta Delta C) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00075","article-title":"Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders","author":"Maffioletti","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb2010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/mol.110.068122","article-title":"The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence","volume":"79","author":"Mao","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0047-6374(01)00221-4","article-title":"Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective","volume":"122","author":"Mattson","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0135","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.euroneuro.2018.06.007","article-title":"Peripheral blood SIRT1 mRNA levels in depression and treatment with electroconvulsive therapy","volume":"28","author":"McGrory","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0140","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.pnpbp.2011.04.013","article-title":"Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients","volume":"35","author":"Minelli","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0145","first-page":"53","article-title":"MicroRNAs as biomarkers for psychiatric conditions: a review of current research","volume":"14","author":"Narahari","year":"2017","journal-title":"Inn. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0150","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1541-7786.MCR-10-0344","article-title":"miR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting Cyclin E","volume":"9","author":"Ofir","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0155","article-title":"Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation","author":"Orang","year":"2014","journal-title":"Int. J. Genom."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.diabres.2015.12.015","article-title":"Type 2 diabetes mellitus disease risk genes identified by genome wide copy number variation scan in normal populations","volume":"113","author":"Prabhanjan","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb2005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4161\/cbt.5.7.2750","article-title":"Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF","volume":"5","author":"Reimer","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jad.2015.11.052","article-title":"Depression and telomere length: a meta-analysis","volume":"191","author":"Ridout","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0175","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.51","article-title":"Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study","author":"Ryan","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0185","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/appi.ajp.2015.15030372","article-title":"Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial","volume":"173","author":"Semkovska","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0195","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pnpbp.2013.01.003","article-title":"The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients","volume":"43","author":"Shibata","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psych."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/YCT.0000000000000118","article-title":"Mechanisms of ECT reviewing the science and dismissing the myths","volume":"30","author":"Sienaert","year":"2014","journal-title":"J. ECT."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0205","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dnarep.2004.03.034","article-title":"The emerging role of E2F-1 in the DNA damage response and checkpoint control","volume":"3","author":"Stevens","year":"2004","journal-title":"DNA Repair"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet (Lond. Eng.)"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061836","article-title":"Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells","author":"Valle","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0220","article-title":"E2F1 hinders skin wound healing by repressing vascular endothelial growth factor (VEGF) expression, neovascularization, and macrophage recruitment","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0225","first-page":"327","article-title":"Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis","volume":"2","author":"Wilkinson","year":"2017","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pscychresns.2015.01.007","article-title":"PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression","volume":"232","author":"Wolkowitz","year":"2015","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0235","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1096\/fj.02-0311fje","article-title":"Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells","volume":"16","author":"Won","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0240","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1073\/pnas.0401801101","article-title":"Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells","volume":"101","author":"Won","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0245","author":"World Health Organisation"},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0250","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvu222","article-title":"E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression","volume":"104","author":"Wu","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5582\/ddt.2016.01003","article-title":"Angiogenesis in refractory depression: a possible phenotypic target to avoid the blood brain barrier","volume":"10","author":"Yamada","year":"2016","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.pnpbp.2018.10.011_bb0260","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1096\/fj.02-0515com","article-title":"Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression","volume":"17","author":"Zhu","year":"2003","journal-title":"FASEB J."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618305827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618305827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:47:51Z","timestamp":1759520871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618305827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":56,"alternative-id":["S0278584618305827"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.10.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral blood E2F1 mRNA in depression and following electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}